AbbVie's Rinvoq shows superiority over Humira in head-to-head arthritis study

AbbVie said on Monday its newer arthritis drug Rinvoq showed superiority over the company's previous bestseller Humira in a ...

AbbVie's Rinvoq shows superiority over Humira in head-to-head study

(Reuters) -AbbVie said on Monday its newer arthritis drug Rinvoq showed superiority over the company's previous bestseller ...
Fierce Pharma

TV drug ad spending sinks 19% in Q3 despite football season uptick in September

In Q3, the top 10 TV ad spenders poured a combined $544.8 million into airing their commercials, according to data shared ...
Medical Marketing & Media

Five things for pharma marketers to know for Tuesday, October 21, 2025

AbbVie said its Rinvoq showed superiority over the company’s previous bestselling drug Humira in a head-to-head trial. Results showed that 43% of patients compared to 22% of patients on Humira ...

Here's What to Expect From AbbVie's Oncology Segment in Q3 Earnings

ABBV's oncology lineup, spanning blood and solid tumor drugs, faces modest Q3 growth as new launches offset Imbruvica's ...
Gastroenterology Advisor

Rinvoq Receives FDA Approval for Updated IBD Indications

The label update provides an option for patients who have received at least 1 approved systemic therapy if TNF blockers are clinically inadvisable.
Penticton Herald

“We Are Not Just Case Numbers,” Selkirk Woman Alleges Retaliation and Health Harm as Disability Support Delays Persist

A Selkirk woman living with a disability says she’s spent more than a year fighting Manitoba’s income support system over ...